Deutsche Bank Ag\ Icosavax, Inc. Transaction History

Deutsche Bank Ag\

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$5.95 - $15.79 $2,076 - $5,510	349 Added 3.28%	11,003 $173,000
Q2 2023 Aug 14, 2023	SELL	$4.89 - $10.57 $16,953 - $36,646	-3,467 Reduced 24.55%	10,654 $105,000
Q1 2023 May 15, 2023	BUY	$5.62 - $11.51 $21,563 - $44,163	3,837 Added 37.31%	14,121 $81,000
Q4 2022 Feb 13, 2023	BUY	$2.32 - $10.97 $348 - $1,645	150 Added 1.48%	10,284 $81,000
Q3 2022 Nov 14, 2022	SELL	$3.09 - $9.21 $4,604 - $13,722	-1,490 Reduced 12.82%	10,134 $32,000
Q2 2022 Aug 11, 2022	SELL	$5.7 - $10.33 $11,964 - $21,682	-2,099 Reduced 15.3%	11,624 $67,000
Q1 2022 May 13, 2022	BUY	$4.41 - $22.5 $22,693 - $115,785	5,146 Added 60.0%	13,723 $96,000
Q4 2021 Feb 11, 2022	BUY	$21.07 - $34.98 $9,060 - $15,041	430 Added 5.28%	8,577 $196,000
Q3 2021 Nov 04, 2021	BUY	$24.85 - $40.25 $202,452 - $327,916	8,147 New	8,147 $241,000

1.37M

Ticker ICVX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,885,200
Description
Icosavax, Inc., a biopharmaceutical company, develops vaccines against infectious diseases. The company, with the help of its virus-like particle (VLP) platform technology, focuses primarily on life-threatening respiratory diseases. Its products in pipeline include IVX-121, a vaccine candidate with RSV target and is under Phase 1/1b clinical tri...

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

Stay updated on Deutsche Bank Ag\ with notifications on news.